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Background: Blast wounds often involve diverse tissue types and require substantial time and treatment for
appropriate healing. Some of these subsequent wounds become colonized with bacteria requiring a better
understanding of how the host responds to these bacteria and what proteomic factors contribute wound healing
outcome. In addition, using reliable and effective proteomic sample preparation procedures can lead to novel
biomarkers for improved diagnosis and therapy.
Results: To address this need, suitable sample preparation for 2-D DIGE proteomic characterization of wound
effluent and serum samples from combat-wounded patients was investigated. Initial evaluation of crude effluent
and serum proved the necessity of high abundant protein depletion. Subsequently, both samples were successfully
depleted using Agilent Multiple Affinity Removal system and showed greatly improved 2-D spot maps, comprising
1,800 and 1,200 protein spots, respectively.
Conclusion: High abundant protein removal was necessary for both wound effluent and serum. This is the first
study to show a successful method for high abundant protein depletion from wound effluent which is compatible
with downstream 2-D DIGE analysis. This development allows for improved biomarker discovery in wound effluent
and serum samples.
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Blast- and other combat wounds continue to be difficult
to treat due to the complex interplay between the patient’s
response to injury and the local wound environment [1-4].
A better understanding of the host systemic response to
the injury and microbial colonization as well as the local
wound microenvironment is essential in order to better
identify a biomarker panel of predictors for wound healing
or dehiscence [1]. Serum and effluent are both ideal bio-
logical samples for studying host proteins because they
are representative of the current state of healing and the
severity of microbial colonization. Serum is considered
the most informative sample type for describing a patient’s
current state of disease and systemic inflammatory re-
sponse, because it contains a combination of all the* Correspondence: brett.chromy@ucdmc.ucdavis.edu
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reproduction in any medium, provided the ordifferentiated sub-proteomes around the body [5]. Simi-
larly, wound effluent is also considered a highly revealing
biological fluid, because it directly reflects the wound site’s
microenvironment which displays the damaged tissue’s
current mechanisms of repair [6]. Because both sample
types are easily obtained through minimally invasive
procedures, they are ideal candidates for identification
of biomarkers that can discriminate between stages of
healing or microbial infection.
Techniques for biomarker discovery are constantly
evolving to improve sensitivity and accuracy. Suitable
preparation of the sample is critical for obtaining reliable
and consistent results for proteomic analysis [7,8]. In
addition, samples directly obtained from blood (serum) or
containing portions of blood proteins (effluent) present
significant analytical challenges for analyzing the full dy-
namic range of the complex proteome. The difficulties are
derived from the vast concentration differences, from
serum albumin ~45 mg/ml to lower abundant proteins asl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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Current understanding is that biomarkers will originate
from cellular interactions into blood and lymph or secre-
tions from the affected tissue and will, therefore, be present
in much lower concentrations than high abundant originat-
ing blood proteins [5]. Proteins with larger abundance mask
those that are less abundant and need to be removed in
order to analyze the lower abundant proteins to evaluate
their usefulness as candidate biomarkers [9].
It is well established that serum gel-based proteomic
analysis is greatly improved after removing high abundant
proteins, but is the same true for wound effluent? Typically
wound effluent consists of plasma, red and white blood
cells, platelets, inflammatory proteins, enzymes and growth
factors. Only a few research groups have performed 2-D-
gel proteomics directly on wound effluent fluid and studied
different types of wounds (chronic wound healing [6], leg
ulcer wounds [10], snake venom damaged tissue [11]), each
of which leads to a different combination of proteins com-
prising the fluid. However, effluent proteome of military
combat blast wounds has yet to be analyzed or character-
ized. A consistently successful method for high abundant
protein removal is Agilent’s Multiple Affinity Removal
System [12-16], which is designed for blood plasma/serum
and it has been successfully tested on other biological
fluids, such as urine [16], CSF [17]. The Multiple Affinity
Removal Column, nonetheless, has not been tested for
effectiveness or compatibility on wound effluent. It is
designed to specifically remove six high abundant proteins
(albumin, IgA, IgG, antitrypsin, transferrin and haptoglobin)
that comprise 85-90% of the total serum protein content,
which results in an expected increase of loading capacity
for lower abundant proteins by up to ten-fold [12].
Other methods for removing high abundant proteins
exist including some that remove higher numbers of pro-
teins, such as CaptureSelect (14 proteins) [18], IgY microbe-
ads (12 proteins) [19], and MARS Hu-14 (14 proteins) and
Proteoprep (20 proteins) [13]. However, we used the top-6
removal for wound effluent which provided a set of putative
biomarkers for wound healing [20]. Several proteins found
in that study would have been removed using these higher
number abundant removal techniques.
In this study, we aim to (1) evaluate the proteome
of crude wound effluent to determine whether effluent
proteomic analysis would benefit by removal of high abun-
dant proteins and (2) present a successful depletion method
for serum and wound effluent that is compatible with
improved downstream 2-D DIGE analysis.
Materials and methods
Sample collection
The study methodology is as reported elsewhere [1,3] and
is reiterated here for completeness. In brief, serial effluent
and serum samples were collected in an observational studywith prospective data collection in accordance with the
institutional review board of the Walter Reed National
Military Medical Center (Bethesda, MD). All patients
were evacuated to the National Capital Area from Iraq and
Afghanistan that had sustained high-energy penetrating
injuries to one or more extremities and were without
confounding co-morbid conditions, such as immune disor-
ders, connective tissue disorders, or any conditions requir-
ing immunosuppressive agents, were eligible for inclusion.
Surgical debridement, lavage, and negative-pressure wound
therapy (NPWT) were repeated every 48–72 hours until
surgical wound closure or coverage at the discretion of
the attending surgeon and in accordance with current
institutional standards of practice.
Wound effluent and serum samples were collected
2 hours following the first surgical debridement and
over a 12-hour period prior to each subsequent wound
debridement. Wound effluent samples (≥30 mL) were
collected using the NPWT canister (without gel pack;
Kinetic Concepts, Inc., San Antonio, TX). For serum
samples, whole blood was collected in red top tubes
and allowed to clot at room temperature for 30 min.
Both samples were centrifuged at 2500 x g for 10 minutes
to remove particulate matter and emboli. Effluent super-
natants and serum were transferred to individually labeled
polypropylene tubes, flash-frozen in liquid nitrogen, and
stored at -80ºC until analysis.
High abundant protein removal
Depletion of high abundant proteins was performed accord-
ing to manufacturer’s instructions (Agilent Technologies).
Briefly, human effluent or serum was diluted five times in
Buffer A (40 μl sample and 160 μl of buffer, 200 μl total
volume) and spun through a 0.22 micron spin filter tube
(Millipore) at 16,000 x g for 5 min to remove particulates.
Then effluent or serum was processed using 4.6 x 100 mm
Multiple Affinity Removal Column Human-6 (Agilent
Technologies), which specifically removes albumin, IgA,
IgG, antitrypsin, transferrin and haptoglobin. A low abun-
dant protein fraction was collected for each sample.
Fractions were concentrated by precipitating with an
equal volume of 20% trichloroacetic acid solution and
incubated at 4°C for 30 min. Precipitate was spun down
and washed twice with cold 100% acetone, allowed to
air dry and then resuspended in DIGE labeling buffer
(7 M urea, 2 M thiourea, 4% CHAPS, 30 mM Tris, pH 8.5).
Protein quantification was performed using Precision Red
Advanced Protein Assay Reagent (Cytoskeleton).
SDS-PAGE
Crude and high abundant protein depleted effluent or
serum samples (5 μg) were appropriately mixed with 5X
sample loading buffer (0.2 M Tris pH 6.8, 20% glycerol,
10% SDS, 5% BME), boiled for 10 min at 100°C and
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was stained for total protein using Sypro Ruby Protein Gel
Stain (Invitrogen, S-12000) and visualized with UVP’s
BioChemi system (UVP BioImaging Systems).
2-D DIGE
Crude and high abundant protein depleted effluent and
serum samples were separated in 2 dimensions accord-
ing to GE Life Sciences Ettan DIGE system protocol.
Briefly, each sample (50 μg) was minimally labeled with
1 μl of 200 pM Cy2, Cy3 or Cy5 for 30 min. Labeling
reactions were stopped by the addition of 1 μl of 1 mM
lysine. The samples were pooled together and added to
rehydration buffer (7 M urea, 2 M thiourea, 4% CHAPS,
1.2% DeStreak, 1% pharmalytes). A final volume of 450 μl
sample was loaded onto 24 cm ph3-10NL Immobiline
DryStrips (GE Life Sciences) and focused by active
overnight rehydration, followed by isoelectric focusing
for a total of 62,500 Vhrs. Strips were equilibrated in
SDS equilibration buffer (6 M urea, 30% glycerol, 2% SDS)Figure 1 Experimental design. Crude effluent and serum were passed th
abundant protein removal. Low abundant proteins were used for Cy2 labefor 15 min with 10 mg/ml DTT, then 15 min in fresh
buffer with 25 mg/ml 15 min with IAA, then applied to
DIGE gels (GE Life Sciences) for 2nd dimension separ-
ation. The resulting CyDye labeled protein gels were
scanned using 100 micron resolution on Typhoon 9410
(GE Life Sciences).
Image analysis
Data analysis was carried out using DeCyder 2-D 7.0 soft-
ware (GE Life Sciences). Spot detection and abundance
quantification was performed using the differential in-gel
analysis (DIA) module of DeCyder.
Results
The key objective of this study was to evaluate the crude
wound effluent proteome and identify a suitable sample
preparation method for both wound effluent and serum for
2-D DIGE blast wound characterization, the approach is
summarized in Figure 1. Crude serum is regularly subjected
to high abundant protein removal prior to being analyzedrough a multiple affinity removal human top-6 column for high
ling and subsequent 2-D DIGE experimental analysis.
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there is little known about wound effluent proteomic
sample preparation. Crude effluent and serum were
independently subjected to high abundant protein removal
using Agilent Human top-6 column according to manufac-
turer’s instructions. Removal efficacy was evaluated by
SDS-PAGE and 2-D DIGE by comparing crude sample
to after high abundant protein removal.Effluent and serum SDS-PAGE analysis after high abundant
protein removal
Initial evaluation of crude effluent (Figure 2, lanes 2 and 5)
and serum (Figure 2, lanes 8 and 11) by SDS-PAGE displays
effluent to have a very similar overall banding pattern when
compared to serum. They both show the characteristic
large, wide albumin band which clearly verifies the necessity
of high abundant protein removal for both sample types.
Corresponding low abundant fractions of effluent (Figure 2,
lanes 3 and 6) and serum (Figure 2, lanes 9 and 12) show a
much improved overall distribution of the proteomic bands.
The high abundant protein fractions for effluent (Figure 2,
lanes 4 and 7) and serum (Figure 2, lanes 10 and 13)
illustrate removal of the targeted six high abundant proteins
(albumin, IgG, IgA, transferrin, haptoglobin and antitrypsin).
Additional detected bands in the high abundant protein
fraction not positioned at one of the full kDa size proteins
have been previously shown to be oligomers or fragments
of one of these six proteins [15].Figure 2 SDS-PAGE of effluent and serum samples after high abunda
Lanes 2 and 5: Crude effluent. Lanes 3 and 6: High abundant protein deple
Lanes 8 and 11: Crude serum. Lanes 9 and 12: High abundant protein depl
Approximately 5 μg protein was loaded into each lane, proteins were visua2-D DIGE analysis of effluent and serum after high
abundant protein removal
Crude effluent and high abundant depleted effluent
(50 μg each) were individually labeled with Cy3 and Cy5,
respectively, and separated in two dimensions, the resulting
2-D gel images are shown in Figure 3. Overlay (Figure 3A)
of crude effluent (Cy3/green) and high abundant depleted
effluent (Cy5/red) clearly demonstrates the specific removal
of high abundant protein spots (primarily green spots),
especially in the higher molecular weight section of the gel.
High abundant depleted effluent enables the appearance of
numerous lower abundant proteins (red spots) that are
now detectable. Individual spot maps were analyzed by
DeCyder resulting in 1000 protein spots detected in crude
effluent (Figure 3B) and 1600 protein spots in high abun-
dant depleted effluent (Figure 3C). Our data validates that
crude wound effluent can be successfully depleted of high
abundant proteins using Agilent’s Multiple Affinity Column
(human top-6) and provide increased detection of lower
abundant proteins by 2-D DIGE.
To evaluate the use of 2-D DIGE for detection of
differential proteins in effluent after removal of high
abundant proteins, three separate patient effluent samples
were similarly depleted of high abundant proteins, labeled
with Cy2, Cy3 and Cy5 and subsequently assessed by 2-D
DIGE, the resulting gel images are shown in Figure 4.
Figure 4A shows the overlay (Cy2/blue, Cy3/green, Cy5/red)
of the three patient effluent samples and clearly displays
the improved distribution of protein spots across thent protein removal. Lane 1: Bio-Rad Precision Plus protein standard.
ted effluent fraction. Lanes 4 and 7: Top-6 protein effluent fraction.
eted serum fraction. Lanes 10 and 13: Top-6 protein effluent fraction.
lized using SYPRO Ruby gel stain.
Figure 3 High abundant protein removal improves spot number and resolution for wound effluent. Panel A shows crude effluent
(Cy3/green) and high abundant protein depleted effluent (Cy5/red) overlayed spot maps from the same initial patient sample analyzed by 2-D
DIGE. Panel B and C, respectively, represent crude effluent (Cy3) and high abundant protein depleted effluent (Cy5). This illustrates the Agilent
Multiple affinity removal top-6 human column worked for wound effluent and greatly improved the overall spot number and quality.
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terns for various proteins. Figure 4B-D presents the
corresponding spot maps for each individual patient ef-
fluent sample. A maximum of 1800 protein spots were
detected, red dots mark the center of each spot detected
by DeCyder. When comparing to the 1000 total spots in
crude effluent, high abundant protein removal signifi-
cantly increases the overall number of detected protein
spots thus increasing the number of potential proteins
that can be assessed for biomarker discovery.
Similarly, serum after high abundant protein removal
from three patients was evaluated by 2-D DIGE, the
gel image is shown in Figure 5A-D. DeCyder analysisdetected 1200 total protein spots, which is a similar to
or exceeds other reports of greater than 1000 2-D gel
spots [9,12,14,15,23,24].
Discussion
A biomarker panel for wound effluent and serum from
blast wound injured patients will help uncover the host
mechanisms of systemic wound healing and response to
microbial colonization. However, no single proteomic
technique exists that can view all regions of the prote-
ome simultaneously for these types of wide dynamic
range biological fluids. Therefore, pre-fractionation or
depletion is a sensible way for analyzing specific
Figure 4 Representative 2-D DIGE gel image of EFFLUENT after high abundant protein depletion. Panel A shows all 3 CyDye fluorescent
spot map images overlayed (Cy2/blue, Cy3/green, Cy5/red). Panel B, C, and D illustrate Cy2, Cy3 and Cy5 individual spot maps, where red dots
define each of the 1800 total protein spots detected.
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interest. This study focuses on (1) evaluating the ne-
cessity of high abundant protein removal for wound ef-
fluent and (2) developing an effective 2-D DIGE sample
preparation method for investigating lower abundant pro-
teins in wound effluent and serum.
Our data clearly demonstrates the similarity of wound
effluent high/low abundant protein proportions to that
of serum (Figures 2,3). In addition, we have successfully
applied the Multiple Affinity Removal Column (human
top-6) for depletion of wound effluent high abundant
proteins which greatly improved the 2-D DIGE spot
map (Figures 3,4). Our results indicate that this depletion
method can be used for both wound effluent and serum
reproducibly and reliably for the detection of differential
proteins. Not only does this result in a dramatic increase
in the visualization and resolution of lower abundant
protein spots, but it also increases the probability of mass
spectrometry identification of differential low abundant
proteins of interest from 2-D DIGE gels.
Other techniques for high abundant protein removal
exist and could be used to provide additional usefulresults for finding differential proteins. The decision
to choose a particular affinity chromatography column
will depend on what proteins might be problematic for
the subsequent proteomic analysis and whether poten-
tial proteins of interest would be removed. Columns
that remove more than the top-6 proteins are able to
deplete additional abundant proteins, which could in-
crease the number of low abundance proteins for sub-
sequent proteomics analysis. For example, one study
used three removal techniques on human plasma and
found that all three gave complementary and overlap-
ping, but different results [13]. Since this report is the
first to describe the high abundant protein removal
from wound effluent, it would be of value to include
different removal techniques in subsequent studies to
complement the results found here. Another important
determination for which high abundant protein removal
technique to use involves the decision to use affinity
column chromatography or affinity bead capture. Each
technique has benefits, but chromatography provides
exceptionally low sample to sample variability [25],
specifically by relying on the use of a chromatography
Figure 5 Representative 2-D DIGE gel image of SERUM after high abundant protein removal. Panel A shows all 3 CyDye fluorescent spot
map images overlayed (Cy2/blue, Cy3/green, Cy5/red). Panel B, C, and D illustrate Cy2, Cy3 and Cy5 individual spot maps, where red dots define
each of the 1200 total protein spots detected.
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errors. Not only should additional affinity depletion
techniques be used to study wound effluent, but other
types of high abundant protein removal, such as the
use of hydrogel particles [26] should provide benefits
forwards biomarker discovery.
Our data provides the necessary method development
to study the host proteome response to blast wound injury
both systemically (serum) and locally (effluent) using
the 2-D DIGE platform. This approach should allow for the
detection and development of novel biomarker panels be-
yond those that are currently commercially available which
offers the potential to improve clinical care.Competing interests
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